首页 > 市场调查报告书 > 医疗设备

病患监测

市场调查报告书

商品编码

1629883

全球家庭医疗保健设备市场 - 2025-2033

Global Home Healthcare Devices Market - 2025-2033

出版日期: 2024年12月30日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024年，全球家庭医疗保健设备市场规模达到462.5亿美元，预计2033年将达到822.7亿美元，2025-2033年预测期间复合年增长率为6.8%。

家庭医疗保健设备是个人可以在家中使用来管理其健康状况的一组医疗设备和技术。个人可以使用这些设备来监测和治疗各种医疗问题，而无需定期前往医疗机构，从而支持更舒适、更方便的医疗保健方法。对家庭护理的需求不断增长反映了医疗保健领域的一个更大趋势，即人们希望在获得必要医疗的同时保持独立性。

患者对家庭治疗的需求增加是预测期内推动市场的驱动因素。有几个因素促成了家庭医疗保健的发展，包括人口老化、慢性病盛行率的增加以及医疗技术的发展提高了家庭护理的可行性和有效性。

市场动态：

驱动程式和限制

患者对家庭治疗的需求增加

患者对家庭治疗的需求增加预计将成为全球家庭医疗设备市场成长的重要因素。这一趋势主要是由几个相互关联的因素推动的，包括人口老化、慢性病盛行率上升、技术进步、在促进有效家庭护理的设备中引入人工智慧。由于老年人的特殊医疗保健需求，不断扩大的老年人口对全球家庭医疗设备市场产生了重大影响。随着年龄的增长，他们更有可能患上需要持续医疗和监测的慢性疾病。

老年人口的增加是家庭治疗需求增加的主要原因之一。例如，据世界卫生组织称，到2050年，80%的老年人将生活在低收入和中等收入国家。人口老化的速度比过去快得多。 2020年，60岁及以上的人口数量超过了5岁以下的儿童数。 2015年至2050年间，全球60岁以上人口比例将增加近一倍，从12%增加至22%。到 2030 年，世界上每 6 人就有 1 人年龄在 60 岁或以上。

各种设备的技术进步、最近的推出以及 FDA 的批准推动了市场的发展。例如，2024 年 11 月，美敦力 (Medtronic) 的新型 InPen 智慧型手机软体获得美国食品药物管理局 (FDA) 批准，并宣布发布全新 Smart MDI 系统。 Smart MDI 旨在为使用者提供有关每日多次注射 (MDI) 治疗的即时资讯。

此外，2024 年9 月，雅培实验室(Abbott Laboratories) 宣布其非处方连续血糖监测仪Lingo 在美国上市。会出现血糖峰值。

设备成本高

设备成本高等因素预计将阻碍全球家庭医疗设备市场。医疗器材的高成本是潜在消费者的主要担忧。许多家庭保健产品，如胰岛素帮浦、雾化器和先进的监测系统，价格昂贵，可能会阻碍患者购买。在此类设备的保险覆盖范围较低或不存在的地区尤其如此，需要患者自行承担全部费用。例如，胰岛素输送系统的平均价格为 3,000 美元至 6,000 美元。这凸显了人们在使用这些重要设备时所承受的巨大成本负担。

Home healthcare devices are a set of medical devices and technologies that individuals can use at home to manage their health conditions. Individuals can use these devices to monitor and treat a variety of medical concerns without having to make regular visits to healthcare institutions, supporting a more comfortable and convenient approach to healthcare. The growing demand for home-based care reflects a larger trend in the healthcare sector, in which people want to keep their independence while obtaining necessary medical treatment.

The increased patient demand for home-based treatments is the driving factor that drives the market over the forecast period. Several factors contribute to this move toward home healthcare, including an aging population, an increase in the prevalence of chronic diseases, and developments in medical technology that improve the feasibility and effectiveness of home-based care.

Market Dynamics: Drivers & Restraints

Increased patient demand for home-based treatments

The increased patient demand for home-based treatments is expected to be a significant factor in the growth of the global home healthcare devices market. This trend is primarily fueled by several interconnected factors, including the aging population, the rising prevalence of chronic diseases, and advancements in technology, introduction of artificial intelligence in the devices that facilitate effective care at home. The expanding geriatric population has a substantial impact on the global home medical equipment market, owing to older persons' specific healthcare needs. As people age, they are more likely to develop chronic diseases that require continuing medical treatment and monitoring.

The increase in the geriatric population is one of the major reasons for the increasing demand of the home-based treatment. For instance, according to WHO, in 2050, 80% of older people will be living in low- and middle-income countries. The pace of population aging is much faster than in the past. In 2020, the number of people aged 60 years and older outnumbered children younger than 5 years. Between 2015 and 2050, the proportion of the world's population over 60 years will nearly double from 12% to 22%. By 2030, 1 in 6 people in the world will be aged 60 years or over.

The technological advancements, recent launches, and FDA approvals of various devices drives the market. For instance, in November 2024, Medtronic received U.S. Food and Drug Administration (FDA) approval for its new InPen smartphone software and announced the release of its new Smart MDI system. Smart MDI was created to give users real-time information about multiple daily injection (MDI) therapy.

Moreover, in September 2024, Abbott Laboratories announced that its over-the-counter continuous glucose monitor Lingo is available in the U.S. One of Abbott's primary goals is to help Lingo users learn about glucose spikes, which occur when the amount of sugar present in the bloodstream rapidly increases and then decreases.

High costs of devices

Factors such as high costs of devices are expected to hamper the global home healthcare devices market. The high cost of medical devices is a major concern for potential consumers. Many home healthcare products, such as insulin pumps, nebulizers, and advanced monitoring systems, come with high prices that may hinder patients from purchasing them. This is especially true in areas where insurance coverage for such devices is low or non-existent, requiring patients to face the entire expense themselves. For instance, the average price of the insulin delivery system ranges from $3,000 to $ 6,000. This highlights the substantial cost burden that people suffer when using these vital devices.

Segment Analysis

The global home healthcare devices market is segmented based on therapeutic devices, monitoring devices, mobility care devices, distribution channels, and region.

Monitoring devices segment is expected to dominate the global home healthcare devices market share

The monitoring devices segment is anticipated to dominate the global home healthcare devices market. The monitoring devices segment is expected to lead the worldwide home healthcare devices market due to several interconnected variables that represent the changing face of healthcare. As chronic diseases become more common, there is an increased demand for ongoing health monitoring, particularly among older persons and those with long-term health concerns. This shift toward proactive health management stresses the relevance of patient monitoring devices, which enable people to follow vital signs and other health metrics from home, allowing for more prompt interventions and lowering the need for hospital visits.

For instance, in August 2024, Dexcom announced the launch of an over-the-counter continuous glucose monitor. Dexcom's Stelo monitors blood glucose levels constantly via a wearable sensor and an application on the user's smartphone or other smart device. Moreover, in June 2024, Prevounce Health, a leading provider of remote care management software, devices, and services, announced the launch of its first remote blood glucose monitoring device, Pylo GL1-LTE. The blood glucose meter has been scientifically tested and linked to numerous cellular networks to guarantee more dependable data transmission across the United States. The GL1-LTE is compatible with the Prevounce remote care management platform and may be integrated with other health software using the Pylo cloud API. Prevounce's Pylo cellular-connected gadgets include blood pressure monitors and weight scales.

Geographical Analysis

North America is expected to hold a significant position in the global home healthcare devices market share

North America is expected to hold a significant portion of the global home healthcare devices market. North America will likely dominate the global home healthcare devices market, owing to a combination of demographic, economic, and technical factors. The region benefits from a well-established healthcare infrastructure that encourages the use of home healthcare solutions. As the geriatric population and frequency of chronic diseases increases, so does the demand for home medical equipment that enables patients to properly manage their health conditions from the comfort of their own homes. This trend to home-based treatment not only improves patient comfort but also decreases the pressure on healthcare facilities, making it a popular choice among many individuals and families.

For instance, according to urban.org, the number of Americans aged 65 and older will more than double over the next 40 years, reaching 80 million in 2040. The number of adults ages 85 and older, the group most often needing help with basic personal care, will nearly quadruple between 2000 and 2040. For an instance, according to America Health Ranking.org, 17.3% of the entire US population is geriatric population.

There are major players present in this region which makes this region the most dominating. For instance, in November 2024, Medtronic received U.S. Food and Drug Administration (FDA) approval for its new InPen smartphone software and announced the release of its new Smart MDI system. Smart MDI was created to give users real-time information about multiple daily injection (MDI) therapy.

Asia Pacific is growing at the fastest pace in the global home healthcare devices market

The Asia Pacific region is emerging as the fastest-growing market for home healthcare devices. One of the major contributions to this growth is the rising prevalence of chronic diseases in the population and the increasing geriatric population. Diabetes, cardiovascular diseases, and respiratory ailments are growing increasingly prevalent as people's lifestyles change and urbanization accelerates. The rise in chronic diseases demands continual monitoring and management, making home medical devices crucial for individuals who prefer to manage their health at home rather than visit healthcare facilities.

The increasing geriatric population is one of the driving factors in this region making it the fastest growing region. For instance, according to the UNFPA India, the current elderly population of 153 million (aged 60 and above) is expected to reach a staggering 347 million by 2050.

Competitive Landscape

The major global players in the global home healthcare devices market include Invacare Corporation, Karman Healthcare Inc., Ottobock, Pride Mobility Products Corp., Medtronic, Sunrise Medical, Meyra GmbH, Koninklijke Philips N.V., Nihon Kohden Corporation, Danaher Corporation among others.

Emerging Players

Livongo, Tyto Care, and iRhythm Tech among others

Key Developments

In August 2024, Hong Kong-based health tech start-up Libpet introduced its innovative smart robot wheelchairs, designed not only for the physically challenged but for everyone. By reducing physical effort, the inclusive device enhances mobility and productivity, making life significantly easier.
In November 2023, DuPont announced a collaboration between DuPont Liveo Healthcare Solutions and STMicroelectronics, a global leader in semiconductor technology. Together, they are working on the development of a new smart wearable device concept aimed at remote biosignal monitoring.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global home healthcare devices market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Therapeutic Devices
3.2. Snippet by Monitoring Devices
3.3. Snippet by Mobility Care Devices
3.4. Snippet by Distribution Channel
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
- 4.1.2. Increased Patient Demand For Home-based Treatments
- 4.1.3. Restraints
- 4.1.4. High Cost of Medical Equipment
- 4.1.5. Opportunity
- 4.1.6. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion

6. By Therapeutic Devices

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapeutic Devices
- 6.1.2. Market Attractiveness Index, By Therapeutic Devices
6.2. Insulin Delivery Systems*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Home Dialysis Machines
6.4. Respiratory Devices
6.5. Others

7. By Monitoring Devices

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Monitoring Devices
- 7.1.2. Market Attractiveness Index, By Monitoring Devices
7.2. Blood Glucose Meters*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Blood Pressure Monitors
7.4. Temperature Monitoring Devices
7.5. Pulse Oximeters
7.6. Others

8. By Mobility Care Devices

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility Care Devices
- 8.1.2. Market Attractiveness Index, By Mobility Care Devices
8.2. Wheelchairs*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Walkers
8.4. Mobility Scooters
8.5. Others

9. By Distribution Channel

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 9.1.2. Market Attractiveness Index, By Distribution Channel
9.2. Hospital Pharmacies*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Retail Pharmacies
9.4. Online Pharmacies

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), Therapeutic Devices
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Monitoring Devices
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility Care Devices
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 10.2.8. The U.S.
- 10.2.9. Canada
- 10.2.10. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), Therapeutic Devices
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Monitoring Devices
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility Care Devices
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 10.3.8. Germany
- 10.3.9. UK
- 10.3.10. France
- 10.3.11. Italy
- 10.3.12. Spain
- 10.3.13. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), Therapeutic Devices
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Monitoring Devices
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility Care Devices
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 10.4.8. Brazil
- 10.4.9. Argentina
- 10.4.10. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), Therapeutic Devices
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Monitoring Devices
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility Care Devices
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 10.5.8. China
- 10.5.9. India
- 10.5.10. Japan
- 10.5.11. South Korea
- 10.5.12. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), Therapeutic Devices
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Monitoring Devices
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility Care Devices
- 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Invacare Corporation*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Karman Healthcare Inc.
12.3. Ottobock
12.4. Pride Mobility Products Corp.
12.5. Medtronic
12.6. Sunrise Medical
12.7. Meyra GmbH
12.8. Koninklijke Philips N.V.
12.9. Nihon Kohden Corporation
12.10. Danaher Corporation

LIST NOT EXHAUSTIVE